• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-30c通过调控乳腺癌细胞中的YWHAZ参与对阿霉素的耐药性。

Involvement of miR-30c in resistance to doxorubicin by regulating YWHAZ in breast cancer cells.

作者信息

Fang Y, Shen H, Cao Y, Li H, Qin R, Chen Q, Long L, Zhu X L, Xie C J, Xu W L

机构信息

Department of Central Laboratory, The First Affiliated People's Hospital, Jiangsu University, ZhenjiangJiangsu, China, Department of Central Laboratory, The First Affiliated People's Hospital, Jiangsu University, Zhenjiang, Jiangsu, China.

Department of Oncology, The First Affiliated People's Hospital, Jiangsu University, ZhenjiangJiangsu, China, Department of Oncology, The First Affiliated People's Hospital, Jiangsu University, Zhenjiang, Jiangsu, China.

出版信息

Braz J Med Biol Res. 2014 Jan;47(1):60-9. doi: 10.1590/1414-431X20133324. Epub 2014 Jan 10.

DOI:10.1590/1414-431X20133324
PMID:24519092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3932974/
Abstract

MicroRNAs (miRNAs) are small RNA molecules that modulate gene expression implicated in cancer, which play crucial roles in diverse biological processes, such as development, differentiation, apoptosis, and proliferation. The aim of this study was to investigate whether miR-30c mediated the resistance of breast cancer cells to the chemotherapeutic agent doxorubicin (ADR) by targeting tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ). miR-30c was downregulated in the doxorubicin-resistant human breast cancer cell lines MCF-7/ADR and MDA-MB-231/ADR compared with their parental MCF-7 and MDA-MB-231 cell lines, respectively. Furthermore, we observed that transfection of an miR-30c mimic significantly suppressed the ability of MCF-7/ADR to resist doxorubicin. Moreover, the anti-apoptotic gene YWHAZ was confirmed as a target of miR-30c by luciferase reporter assay, and further studies indicated that the mechanism for miR-30c on the sensitivity of breast cancer cells involved YWHAZ and its downstream p38 mitogen-activated protein kinase (p38MAPK) pathway. Together, our findings provided evidence that miR-30c was one of the important miRNAs in doxorubicin resistance by regulating YWHAZ in the breast cancer cell line MCF-7/ADR.

摘要

微小RNA(miRNA)是一类小RNA分子,可调节与癌症相关的基因表达,在发育、分化、凋亡和增殖等多种生物学过程中发挥关键作用。本研究旨在探讨miR-30c是否通过靶向酪氨酸3-单加氧酶/色氨酸5-单加氧酶激活蛋白ζ(YWHAZ)介导乳腺癌细胞对化疗药物阿霉素(ADR)的耐药性。与亲本MCF-7和MDA-MB-231细胞系相比,阿霉素耐药的人乳腺癌细胞系MCF-7/ADR和MDA-MB-231/ADR中miR-30c分别下调。此外,我们观察到转染miR-30c模拟物可显著抑制MCF-7/ADR抵抗阿霉素的能力。此外,荧光素酶报告基因检测证实抗凋亡基因YWHAZ是miR-30c的靶标,进一步研究表明miR-30c影响乳腺癌细胞敏感性的机制涉及YWHAZ及其下游的p38丝裂原活化蛋白激酶(p38MAPK)途径。总之,我们的研究结果表明,在乳腺癌细胞系MCF-7/ADR中,miR-30c通过调节YWHAZ成为阿霉素耐药中重要miRNA之一。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e3/3932974/def9a20bf89d/1414-431X-bjmbr-47-01-00060-gf005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e3/3932974/6a4031e6d05c/1414-431X-bjmbr-47-01-00060-gf001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e3/3932974/ce042f564057/1414-431X-bjmbr-47-01-00060-gf002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e3/3932974/9f88036e6a16/1414-431X-bjmbr-47-01-00060-gf003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e3/3932974/a9be0873d7cf/1414-431X-bjmbr-47-01-00060-gf004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e3/3932974/def9a20bf89d/1414-431X-bjmbr-47-01-00060-gf005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e3/3932974/6a4031e6d05c/1414-431X-bjmbr-47-01-00060-gf001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e3/3932974/ce042f564057/1414-431X-bjmbr-47-01-00060-gf002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e3/3932974/9f88036e6a16/1414-431X-bjmbr-47-01-00060-gf003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e3/3932974/a9be0873d7cf/1414-431X-bjmbr-47-01-00060-gf004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12e3/3932974/def9a20bf89d/1414-431X-bjmbr-47-01-00060-gf005.jpg

相似文献

1
Involvement of miR-30c in resistance to doxorubicin by regulating YWHAZ in breast cancer cells.miR-30c通过调控乳腺癌细胞中的YWHAZ参与对阿霉素的耐药性。
Braz J Med Biol Res. 2014 Jan;47(1):60-9. doi: 10.1590/1414-431X20133324. Epub 2014 Jan 10.
2
MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN.MicroRNA-21 通过靶向 PTEN 调节乳腺癌细胞对阿霉素的化疗敏感性。
Arch Med Res. 2011 May;42(4):281-90. doi: 10.1016/j.arcmed.2011.06.008.
3
MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.miR-222 和 miR-29a 有助于乳腺癌细胞的耐药性。
Gene. 2013 Nov 15;531(1):8-14. doi: 10.1016/j.gene.2013.08.062. Epub 2013 Aug 29.
4
Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response.p53 突变型乳腺癌的内在阿霉素耐药性与 miR-30c/FANCF/REV1 介导的 DNA 损伤反应有关。
Cell Death Dis. 2019 Sep 11;10(9):666. doi: 10.1038/s41419-019-1871-z.
5
miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27 pathway.微小RNA-222通过PTEN/Akt/p27信号通路诱导乳腺癌对阿霉素产生耐药性。
Tumour Biol. 2016 Nov;37(11):15315-15324. doi: 10.1007/s13277-016-5341-2. Epub 2016 Oct 4.
6
MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.微小RNA-222通过调控PTEN/Akt/FOXO1信号通路促进乳腺癌细胞对阿霉素的耐药性。
Gene. 2017 Jan 5;596:110-118. doi: 10.1016/j.gene.2016.10.016. Epub 2016 Oct 13.
7
Effect of miR-7 on resistance of breast cancer cells to adriamycin via regulating EGFR/PI3K signaling pathway.miR-7 通过调节 EGFR/PI3K 信号通路对乳腺癌细胞多柔比星耐药性的影响。
Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5285-5292. doi: 10.26355/eurrev_201906_18195.
8
Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway.霍诺酚拮抗 miR-188-5p/FBXW7/c-Myc 通路逆转人乳腺癌多柔比星耐药。
Cancer Chemother Pharmacol. 2021 May;87(5):647-656. doi: 10.1007/s00280-021-04238-w. Epub 2021 Feb 5.
9
miR-222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27(kip1) expression.微小RNA-222通过抑制p27(kip1)的表达赋予乳腺癌细胞对阿霉素的抗性。
Gene. 2016 Sep 15;590(1):44-50. doi: 10.1016/j.gene.2016.06.013. Epub 2016 Jun 6.
10
MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.微小RNA-29a通过PTEN/AKT/GSK3β信号通路导致乳腺癌细胞对阿霉素耐药。
Gene. 2016 Nov 15;593(1):84-90. doi: 10.1016/j.gene.2016.08.016. Epub 2016 Aug 11.

引用本文的文献

1
Modulatory effects of miRNAs in doxorubicin resistance: A mechanistic view.miRNAs 在多柔比星耐药中的调控作用:一种机制观点。
Funct Integr Genomics. 2024 Sep 2;24(5):150. doi: 10.1007/s10142-024-01431-x.
2
MiR-30c suppresses the proliferation, metastasis and polarity reversal of tumor cell clusters by targeting MTDH in invasive micropapillary carcinoma of the breast.在乳腺浸润性微乳头状癌中,miR-30c通过靶向MTDH抑制肿瘤细胞簇的增殖、转移和极性逆转。
Heliyon. 2024 Jul 2;10(13):e33938. doi: 10.1016/j.heliyon.2024.e33938. eCollection 2024 Jul 15.
3
Circ_0069094 regulates malignant phenotype and paclitaxel resistance in breast cancer cells via targeting the miR-136-5p/YWHAZ axis.

本文引用的文献

1
Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.miR-195 的上调通过抑制 Raf-1 增加了乳腺癌细胞对阿霉素治疗的敏感性。
Oncol Rep. 2013 Aug;30(2):877-89. doi: 10.3892/or.2013.2532. Epub 2013 Jun 11.
2
MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1.微小RNA-26a通过抑制髓细胞白血病序列1来抑制乳腺癌的增殖和迁移。
PLoS One. 2013 Jun 4;8(6):e65138. doi: 10.1371/journal.pone.0065138. Print 2013.
3
MicroRNA-regulated protein-protein interaction networks and their functions in breast cancer.
环状 RNA 0069094 通过靶向 miR-136-5p/YWHAZ 轴调节乳腺癌细胞的恶性表型和紫杉醇耐药性。
Thorac Cancer. 2023 Jul;14(19):1831-1842. doi: 10.1111/1759-7714.14928. Epub 2023 May 16.
4
The Role of miRNAs in the Resistance of Anthracyclines in Breast Cancer: A Systematic Review.微小RNA在乳腺癌蒽环类药物耐药中的作用:一项系统评价
Front Oncol. 2022 May 12;12:899145. doi: 10.3389/fonc.2022.899145. eCollection 2022.
5
MicroRNA and Alternative mRNA Splicing Events in Cancer Drug Response/Resistance: Potent Therapeutic Targets.微小RNA与癌症药物反应/耐药中的可变mRNA剪接事件:强大的治疗靶点
Biomedicines. 2021 Dec 2;9(12):1818. doi: 10.3390/biomedicines9121818.
6
Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature.循环和细胞内微小RNA作为新辅助化疗治疗HER2阳性早期乳腺癌的预后和预测因素:文献综述
Cancers (Basel). 2021 Sep 29;13(19):4894. doi: 10.3390/cancers13194894.
7
MicroRNAs as a clue to overcome breast cancer treatment resistance.微小 RNA 作为克服乳腺癌治疗耐药性的线索。
Cancer Metastasis Rev. 2022 Mar;41(1):77-105. doi: 10.1007/s10555-021-09992-0. Epub 2021 Sep 15.
8
High miR-30 Expression Associates with Improved Breast Cancer Patient Survival and Treatment Outcome.高 miR-30 表达与乳腺癌患者生存率提高及治疗结果改善相关。
Cancers (Basel). 2021 Jun 10;13(12):2907. doi: 10.3390/cancers13122907.
9
MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells.微小RNA作为乳腺肿瘤细胞中多柔比星耐药性的关键调节因子。
Cancer Cell Int. 2021 Apr 15;21(1):213. doi: 10.1186/s12935-021-01873-4.
10
Downregulation of microRNA-30c-5p was responsible for cell migration and tumor metastasis via COTL1-mediated microfilament arrangement in breast cancer.微小RNA-30c-5p的下调通过乳腺癌中COTL1介导的微丝排列导致细胞迁移和肿瘤转移。
Gland Surg. 2020 Jun;9(3):747-758. doi: 10.21037/gs-20-472.
微小RNA调控的蛋白质-蛋白质相互作用网络及其在乳腺癌中的功能
Int J Mol Sci. 2013 May 30;14(6):11560-606. doi: 10.3390/ijms140611560.
4
Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer.致癌 miR-181a/b 影响侵袭性乳腺癌的 DNA 损伤反应。
Cell Cycle. 2013 Jun 1;12(11):1679-87. doi: 10.4161/cc.24757. Epub 2013 May 1.
5
miR-221 promotes tumorigenesis in human triple negative breast cancer cells.miR-221 促进人三阴性乳腺癌细胞的肿瘤发生。
PLoS One. 2013 Apr 24;8(4):e62170. doi: 10.1371/journal.pone.0062170. Print 2013.
6
Multiple tumor-associated microRNAs modulate the survival and longevity of dendritic cells by targeting YWHAZ and Bcl2 signaling pathways.多种肿瘤相关 microRNAs 通过靶向 YWHAZ 和 Bcl2 信号通路调节树突状细胞的存活和寿命。
J Immunol. 2013 Mar 1;190(5):2437-46. doi: 10.4049/jimmunol.1202282. Epub 2013 Jan 25.
7
MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11.miRNA-30c 通过调节 TWF1 和 IL-11 抑制人乳腺癌肿瘤化疗耐药性。
Nat Commun. 2013;4:1393. doi: 10.1038/ncomms2393.
8
Sulfuretin-induced miR-30C selectively downregulates cyclin D1 and D2 and triggers cell death in human cancer cell lines.硫化查尔酮诱导的 miR-30C 选择性地下调细胞周期蛋白 D1 和 D2 并触发人癌细胞系的细胞死亡。
Biochem Biophys Res Commun. 2013 Feb 15;431(3):572-8. doi: 10.1016/j.bbrc.2013.01.012. Epub 2013 Jan 11.
9
MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion.微小 RNA-30c 靶向参与乳腺癌细胞侵袭的细胞骨架基因。
Breast Cancer Res Treat. 2013 Jan;137(2):373-82. doi: 10.1007/s10549-012-2346-4. Epub 2012 Dec 7.
10
[Single nucleotide polymorphism in flanking region of miR-30c influences the maturing process of miR-30c in lung carcinoma].[miR-30c侧翼区域的单核苷酸多态性影响肺癌中miR-30c的成熟过程]
Zhonghua Zhong Liu Za Zhi. 2012 Sep;34(9):664-8. doi: 10.3760/cma.j.issn.0253-3766.2012.09.005.